凯文·奥特森《抗生素的终结
在今年夏初的一次会议上，奥特森教授讨论了创造新抗生素的障碍。
波士顿大学 Professor of Law and N. Neal Pike Scholar in Health and Disability Law 凯文Outterson, executive director of BU’s antibiotic accelerator CARB-X, joined a panel of experts to discuss his work on antibiotic resistance at PULSE: On the Front Lines of Health Care, organized by 大西洋. 奥特森讨论了研发方面的障碍，以及制药行业商业模式的问题，这些问题阻碍了新型抗生素的成功开发。
View his panel, “The End of Antibiotics?” below.